Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sensus Healthcare (SRTS) Cash from Financing Activities (2017 - 2025)

Sensus Healthcare (SRTS) has 9 years of Cash from Financing Activities data on record, last reported at -$5000.0 in Q4 2025.

  • For Q4 2025, Cash from Financing Activities fell 117.86% year-over-year to -$5000.0; the TTM value through Dec 2025 reached -$305000.0, down 535.42%, while the annual FY2025 figure was -$305000.0, 2133.33% down from the prior year.
  • Cash from Financing Activities reached -$5000.0 in Q4 2025 per SRTS's latest filing, up from -$300000.0 in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $273000.0 in Q1 2022 and bottomed at -$1.9 million in Q4 2022.
  • Average Cash from Financing Activities over 5 years is -$200400.0, with a median of -$39000.0 recorded in 2023.
  • The widest YoY moves for Cash from Financing Activities: up 555.0% in 2022, down 3481.48% in 2022.
  • A 5-year view of Cash from Financing Activities shows it stood at -$54000.0 in 2021, then crashed by 3481.48% to -$1.9 million in 2022, then surged by 99.64% to -$7000.0 in 2023, then skyrocketed by 500.0% to $28000.0 in 2024, then tumbled by 117.86% to -$5000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Cash from Financing Activities were -$5000.0 in Q4 2025, -$300000.0 in Q1 2025, and $28000.0 in Q4 2024.